Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for Dexcom (DXCM) over the last 6 years, with Q4 2025 value amounting to $295.6 million.

  • Dexcom's Long-Term Deferred Tax fell 3857.02% to $295.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $295.6 million, marking a year-over-year decrease of 3857.02%. This contributed to the annual value of $295.6 million for FY2025, which is 3857.02% down from last year.
  • Latest data reveals that Dexcom reported Long-Term Deferred Tax of $295.6 million as of Q4 2025, which was down 3857.02% from $375.6 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Long-Term Deferred Tax peaked at $501.3 million during Q3 2023, and registered a low of $216.3 million during Q3 2021.
  • In the last 5 years, Dexcom's Long-Term Deferred Tax had a median value of $362.3 million in 2023 and averaged $373.5 million.
  • Per our database at Business Quant, Dexcom's Long-Term Deferred Tax skyrocketed by 5825.24% in 2022 and then plummeted by 3857.02% in 2025.
  • Dexcom's Long-Term Deferred Tax (Quarter) stood at $290.5 million in 2021, then grew by 17.45% to $341.2 million in 2022, then increased by 22.92% to $419.4 million in 2023, then rose by 14.74% to $481.2 million in 2024, then tumbled by 38.57% to $295.6 million in 2025.
  • Its last three reported values are $295.6 million in Q4 2025, $375.6 million for Q3 2025, and $496.3 million during Q2 2025.